Uninterrupted NOACs ‘safe’ in AF catheter ablation

Uninterrupted treatment with novel oral anticoagulants (NOACs) during catheter ablation of atrial fibrillation (AF) is safe, according to German researchers.

Their study of 549 patients who took either a vitamin K antagonist or NOAC found no incidence of stroke, systemic embolism or thromboembolic event.

There was one pericardial effusion in the vitamin K antagonist group and two in the NOAC group. Lead author